The changing therapeutic landscape of head and neck cancer

John D. Cramer(Wayne State University), Barbara Burtness(Yale Cancer Center), Quynh‐Thu Le(Stanford University), Robert L. Ferris(University of Pittsburgh)

Nature Reviews Clinical Oncology

June 12, 2019

10.1038/s41571-019-0227-z

Cited by 807

Abstract

Related Papers

The National Comprehensive Cancer Network

William T. McGivney|Cancer|1998|16.9k

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

Stephen B. Edge, Carolyn C. Compton|Annals of Surgical Oncology|2010|9.2k

Comprehensive genomic characterization of head and neck squamous cell carcinomas

The Cancer Genome Atlas Network|Nature|2015|4.1k

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al.|New England Journal of Medicine|2007|1.7k

Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in <i>NOTCH1</i>

Nishant Agrawal, Mitchell J. Frederick, Curtis R. Pickering et al.|Science|2011|1.7k